Search

everythinglearnresearchcommunity

for

Search:↓

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Upadacitinib may effectively treat alopecia areata without side effects.

Histone modification is key in treating chronic inflammatory skin diseases.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

TNF-alpha inhibitors can cause various immune-related skin issues.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The skin microbiome helps heal wounds and can be targeted to improve healing.

People with alopecia have a higher risk of thyroid cancer.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.